Hongkong XinRunde Chemical Co., Ltd


Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsWeight Loss Powder

Orlistat Weight Loss Powder CAS 96829-58-2 Treating Obesity Slimming

Orlistat Weight Loss Powder CAS 96829-58-2 Treating Obesity Slimming

small.img.alt small.img.alt

Large Image :  Orlistat Weight Loss Powder CAS 96829-58-2 Treating Obesity Slimming Get Best Price

Product Details:
Place of Origin: China
Brand Name: XRD
Certification: GMP
Model Number: 96829-58-2
Payment & Shipping Terms:
Minimum Order Quantity: negotiable
Price: Inquiry for Negotiable
Packaging Details: 1-2 kg / aluminum foil bag, 25kg/ drum, as required
Delivery Time: 1-2days after payment received
Payment Terms: T/T bank, Western Union, Bitcoin, Etc
Supply Ability: 100KG/ Month
Detailed Product Description
CAS: 96829-58-2 Product Name: Orlistat
Type: Weight Loss Powder Appearance: White Powder
Usage: Weight Loss Alias: Orlipastat
Assay: 99% Key Words: Orlistat
High Light:

fat loss powder


fat loss steroids

Weight Loss Powder Orlistat CAS 96829-58-2 Treating Obesity Slimming


Quick detail


Product name: Orlistat
CAS Numbers: 96829-58-2
Appearance: white needle crystal or powder
Quality standard: CP
Packing specification: 1 kg/bag
Melting point: 45

Purity: 98.0%

MF: C29H53NO5

MW: 495.73
Appearance: white powder
Usage: Used for curing obesity



Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.

The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).


Orlistat Weight Loss Powder CAS 96829-58-2 Treating Obesity Slimming 0





1. Orlistat is a drug that promotes loss of weight by preventing the digestion and absorption of fat in food. In the intestine, an enzyme called lipase (produced primarily by the pancreas) breaks apart fat in food so that it can be absorbed into the body.
2. Orlistat blocks the action of lipase and thereby prevents the breakup and absorption of fat. Orlistat blocks absorption of about 25% of the fat in a meal. The unabsorbed fat is excreted in the stool.
3. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.
4. Dietary fats need to be broken down into smaller pieces before the body can absorb them. Orlistat works by blocking the enzyme that breaks down fats in your diet. This undigested fat then passes out of your body in your bowel movement.
5. Orlistat does not block the absorption of calories from sugar and other non-fat foods, so you still need to restrict your total intake of calories.
6. Orlistat is notorious for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools). In the United States and the European Union, orlistat is available for sale without a prescription. Generic formulations of orlistat are available in some countries


Orlistat Weight Loss Powder CAS 96829-58-2 Treating Obesity Slimming 1


Orlistat COA


tems Specification Items Result
Appearance white or almost white crystalline powder,smell less White crystalline powder
Melting Point 42.0~46.0°C Confirmed
Specific Rotation -31°~-39°(CHCl3,C=1) Confirmed
Identification The result of HPLC is consisitent to the reference one. The result of IR is consisitent to the reference one. Confirmed
Related Substances ≤ 0.5% ≤ 0.05%
Total impurity ≤ 1.0% Confirmed
Single impurity ≤ 0.1% Confirmed
  ≤ 290ppm Confirmed
  ≤ 5000ppm Confirmed
Residual on Ignition ≤0.1% Confirmed
Sulphate ≤ 0.05% Confirmed
Heavy Metal ≤ 20ppm Confirmed
Purity ≤ 99.0% ~ 99.9% Confirmed




Weight Loss Powder Orlistat CAS 96829-58-2 Treating Obesity Slimming

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: bruce

Tel: +8618874586545

Send your inquiry directly to us